Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for almost
a fifth of all cancer-related deaths. Annual computed tomographic lung cancer screening …

Nowadays, many relevant drug–gene associations have been discovered, but
pharmacogenomics (PGx)-guided treatment needs to be cost-effective as well as clinically …

Background: Cost-effectiveness analysis is an important tool for informing treatment
coverage and pricing decisions, yet no consensus exists about what threshold for the …

Around the world, governments are starting to directly measure the subjective wellbeing of
their citizens and to use it for policy evaluation and appraisal. What would happen if a …

Background In the face of pressure to contain costs and make best use of scarce nurses,
flexible staff deployment (floating staff between units and temporary hires) guided by a …

Priority setting and net zero healthcare: how much health can a tonne of carbon buy? | The BMJ
Skip to main content Intended for healthcare professionals Access provided by Google Indexer …

Objectives Cost-effectiveness analysis (CEA) embeds an assumption at odds with most
economic analysis–that of constant returns to health in the creation of happiness (utility). We …

Cost-effectiveness analysis (CEA) is a well-known, but resource intensive, method for
comparing the costs and health outcomes of health interventions. To build on available …

Objectives The first objective is to estimate the joint impact of social care, public health and
healthcare expenditure on mortality in England. The second objective is to use these results …

Health economists are currently debating, with some suspicion, the relative merits of cost-
benefit analysis (CBA), grounded in theoretical welfare economics, and the proliferation of …